Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bladder Overactivity and Post-Botulinum Toxin Telemonitoring: a Randomized, Controlled, Superiority Trial

NCT07379372 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT07379372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07379372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bladder Overactivity and Post-Botulinum Toxin Telemonitoring: a Randomized, Controlled, Superiority Trial
Lead sponsor
University Hospital, Grenoble
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 2, 2026
Completion date
March 2, 2031
Enrollment
112 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder